Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo

American Journal of Physiology - Endocrinology and Metabolism

Volumn 281, Issue 4 44-4, 2001, Pages

  Hornbuckle, Lauri A ^a   Edgerton, Dale S ^a   Ayala, Julio E ^a   Svitek, Christina A ^a   Oeser, James K ^a   Neal, Doss W ^a   Cardin, Sylvain ^a   Cherrington, Alan D ^a   O'Brien, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic adenosine monophosphate; Gene transcription; Glucocorticoids; Glucose 6 phosphate; Glucose 6 phosphatase; Insulin

Indexed keywords

CARRIER PROTEIN; CYCLIC AMP; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE TRANSPORTER; INSULIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION REGULATION; HEPATOMA CELL; HYPOINSULINEMIA; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

EID: 0034797471     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.281.4.e713     Document Type: Article

References (70)

1. Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog
2. Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose-1-phosphate
3. Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein
4. Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate
5. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: Gene structure and 5′-flanking sequence
6. Microsomal membrane integrity and the interactions of phlorizin with the glucose-6-phosphatase system
7. Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate
8. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes
9. Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: Transcription factor FKHR binds the insulin response sequence
10. Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R 3401: Inhibition and inactivation of glycogen phosphorylase by an activated metabolite
11. Effect of vagal cooling on the counter-regulatory response to hypoglycemia induced by a low dose of insulin in the conscious dog
12. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: In vivo and in vitro studies in cultured fetal hepatocytes
13. Molecular genetics of type I glycogen storage disease
14. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus
15. Role of liver in pathophysiology of NIDDM
16. p1B15: A cDNA clone of the rat mRNA encoding cyclophilin
17. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
18. Pathogenesis of NIDDM. A balanced overview
19. Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin
20. Compartmental modeling of glucagon kinetics in the conscious dog
21. Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene
22. a- and b-cell responses to small changes in plasma glucose in the conscious dog
23. Regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence
24. Glucose-6-phosphatase structure, regulation, and function: An update
25. Glucose regulation of gene expression
26. Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes
27. Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib
28. A nucleoprotein complex containing C/EBPβ interacts with an insulin response sequence in the IGF binding protein-1 gene and contributes to insulin-regulated gene expression
29. Molecular physiology and genetics of NIDDM. Importance of metabolic staging
30. Insulin suppresses transactivation by C/EBPβ: Signaling to p300/CBP by protein kinase B disrupts interaction with the major activation domain of C/EBPβ
31. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes
32. Characterization of the human cyclophilin gene and of related processed pseudogenes
33. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor binding protein-1 gene expression by insulin
34. Nucleotide sequence of a cDNA coding for mouse cyclophilin
35. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b
36. Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: Identification of mutation in puppies with glycogen storage disease type Ia
37. Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: Regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP
38. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a
39. Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase
40. Distinct hormone stimulation and counteraction by insulin of the expression of the two components of glucose 6-phosphatase in HepG2 cells
41. Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents
42. Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene
43. The role of HNF1α, HNF3γ, and cyclic AMP in glucose-6-phosphatase gene activation
44. Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level
45. Regulation of the glucose-6-phosphatase gene by glucose occurs by transcriptional and post-trancriptional mechanisms. Differential effect of glucose and xylitol
46. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats
47. Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats
48. New knowledge regarding glucose-6 phosphatase gene and protein and their roles in the regulation of glucose metabolism
49. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats
50. Immunoassay of insulin: Two antibody system: Plasma insulin of normal, subdiabetic, and diabetic rats
51. Regulation of gene expression by insulin
52. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription
53. Experimental application of top-down control analysis to metabolic systems
54. The glucose-6 phosphatase gene is expressed in human and rat small intestine: Regulation of expression in fasted and diabetic rats
55. Cloning and sequencing of the 5′ region of the human glucose-6-phosphatase gene: Transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells
56. Regulation of glucose-6-phosphatase gene expression by protein kinase B alpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity
57. Identification of a cAMP response element within the glucose-6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells
58. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes
59. Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A
60. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs
61. Glucose reabsorption in the kidney
62. Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription
63. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin
64. Differential role of hepatocyte nuclear factor-1 in the regulation of glucose-6-phosphatase catalytic subunit gene transcription by cAMP in liver- and kidney-derived cell lines
65. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats
66. New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system
67. Glucose regulation of gene transcription
68. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene
69. Characterization of elements mediating regulation of phosphoenolpyruvate carboxykinase gene transcription by protein kinase A and insulin. Identification of a distinct complex formed in cells that mediate insulin inhibition